Northland Securities Raises Earnings Estimates for Transcat

Posted by Geri Gentry on Nov 6th, 2026

Transcat, Inc. (NASDAQ:TRNS – Free Report) – Equities research analysts at Northland Securities raised their Q3 2027 earnings estimates for shares of Transcat in a report issued on Wednesday, November 4th. Northland Securities analyst T. Jackson now expects that the scientific and technical instruments company will post earnings per share of $0.22 for the quarter, up from their prior estimate of $0.20. Northland Securities currently has an “Outperform” rating and a $95.00 target price on the stock. The consensus estimate for Transcat’s current full-year earnings is $1.84 per share. Northland Securities also issued estimates for Transcat’s Q4 2027 earnings at $0.64 EPS, FY2027 earnings at $2.00 EPS, FY2028 earnings at $2.18 EPS, FY2029 earnings at $2.65 EPS, FY2030 earnings at $3.10 EPS and FY2031 earnings at $3.69 EPS.

Transcat (NASDAQ:TRNS – Get Free Report) last issued its earnings results on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.19. The business had revenue of $97.09 million for the quarter, compared to analyst estimates of $92.46 million. Transcat had a net margin of 1.26% and a return on equity of 6.14%.

A number of other research firms also recently weighed in on TRNS. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Transcat in a report on Tuesday, August 25th. CJS Securities began coverage on Transcat in a report on Tuesday, October 27th. They issued an “outperform” rating and a $115.00 target price for the company. Finally, Oppenheimer upgraded Transcat from a “market perform” rating to an “outperform” rating and set a $115.00 target price for the company in a research report on Wednesday. Three investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $108.33.

View Our Latest Analysis on TRNS

Transcat Stock Performance

NASDAQ:TRNS opened at $100.38 on Friday. Transcat has a 12-month low of $50.23 and a 12-month high of $110.47. The company has a quick ratio of 2.11, a current ratio of 2.57 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $943.57 million, a PE ratio of 209.13 and a beta of 0.61. The firm has a 50-day moving average price of $86.71 and a 200 day moving average price of $82.24.

Institutional Investors Weigh In On Transcat

A number of hedge funds have recently made changes to their positions in the company. R Squared Ltd acquired a new position in Transcat in the third quarter valued at about $274,000. Riverbridge Partners LLC grew its stake in Transcat by 8.4% during the third quarter. Riverbridge Partners LLC now owns 219,452 shares of the scientific and technical instruments company’s stock worth $19,404,000 after buying an additional 17,063 shares during the last quarter. Summit Creek Advisors LLC grew its stake in Transcat by 23.8% during the third quarter. Summit Creek Advisors LLC now owns 58,135 shares of the scientific and technical instruments company’s stock worth $5,140,000 after buying an additional 11,165 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in shares of Transcat during the third quarter worth approximately $221,000. Finally, GAMMA Investing LLC increased its holdings in shares of Transcat by 133.6% during the third quarter. GAMMA Investing LLC now owns 1,030 shares of the scientific and technical instruments company’s stock worth $91,000 after buying an additional 589 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Transcat News Summary

Here are the key news stories impacting Transcat this week:

Positive Sentiment: Transcat beat earnings and revenue estimates, reporting $0.64 per share versus the $0.45 consensus and $97.1 million in revenue versus $92.5 million expected. Service momentum and acquisitions contributed to the above-consensus quarter. Why Transcat Is Up 20.8% And What’s Next After Earnings Beat
Positive Sentiment: Management raised its fiscal 2027 outlook for organic service revenue growth to the low double digits and is targeting at least 100 basis points of service gross-margin expansion in the second half. The company also reported double-digit organic service growth and significant service margin improvement. Transcat raises FY2027 service outlook
Positive Sentiment: Oppenheimer upgraded TRNS from “market perform” to “outperform” and set a $115 price target, signaling improved analyst confidence after the results.
Neutral Sentiment: Shares had surged about 20.8% and reached a record after the earnings release. The subsequent decline may reflect investors taking profits after that rapid move, rather than a negative development reported in these articles.
Negative Sentiment: The sharp post-earnings rally may leave the stock vulnerable to volatility or further profit-taking; the supplied coverage does not identify a new company-specific negative catalyst.

Transcat Company Profile

(Get Free Report)

Transcat, Inc (NASDAQ: TRNS) provides calibration, compliance, and measurement services for organizations that rely on accurate test and measurement equipment. The company supports customers in regulated industries, including life sciences, aerospace and defense, energy, manufacturing, and other industrial markets.

Its service offerings include laboratory and onsite calibration, repair, validation, and asset-management services. Transcat calibrates a broad range of equipment used to measure temperature, pressure, electrical and electronic properties, radio frequency signals, dimensional characteristics, and other technical parameters.